Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A05799 | 33114290 | Int J Mol Sci | The Molecular Mechanisms of Iron Metabolism and Its Role in Cardiac Dysfunction and Cardioprotection. | 2020 | Details |
| A05800 | 33114278 | Antioxidants (Basel) | Consumption of Spinach and Tomato Modifies Lipid Metabolism, Reducing Hepatic Steatosis in Rats. | 2020 | Details |
| A05801 | 33114221 | Antioxidants (Basel) | Auranofin Attenuates Non-Alcoholic Fatty Liver Disease by Suppressing Lipid Accumulation and NLRP3 Inflammasome-Mediated Hepatic Inflammation In Vivo and In Vitro. | 2020 | Details |
| A05802 | 33114148 | Int J Mol Sci | Coenzyme Q10 Supplementation for the Reduction of Oxidative Stress: Clinical Implications in the Treatment of Chronic Diseases. | 2020 | Details |
| A05803 | 33114130 | Nutrients | Bilberry Anthocyanins Ameliorate NAFLD by Improving Dyslipidemia and Gut Microbiome Dysbiosis. | 2020 | Details |
| A05804 | 33113993 | Nutrients | Effects of a Low Dose of Caffeine Alone or as Part of a Green Coffee Extract, in a Rat Dietary Model of Lean Non-Alcoholic Fatty Liver Disease without Inflammation. | 2020 | Details |
| A05805 | 33113887 | Diagnostics (Basel) | Effect of Adult Weight Gain on Non-Alcoholic Fatty Liver Disease and Its Association with Anthropometric Parameters in the Lean Japanese Population. | 2020 | Details |
| A05806 | 33113563 | J Fluoresc | A Bifunctional Coordination Polymer for Al3+ Ion Detection and its Treatment Effect on Nonalcoholic Fatty Liver Disease by Promoting Lipoxygenases and Reducing Intrahepatic Triglyceride Content. | 2020 | Details |
| A05807 | 33113501 | Phytomedicine | Modulation of IR as a therapeutic target to prevent NASH using NRF from Diceratella elliptica (DC.) jonsell. Strong Nrf2 and leptin inducer as well as NF-kB inhibitor. | 2020 | Details |
| A05808 | 33112796 | J Endocrinol | GH directly inhibits steatosis and liver injury in a sex-dependent and IGF1-independent manner. | 2021 | Details |
| A05809 | 33111374 | Hepatology | NAFLD: Reporting Histologic Findings in Clinical Practice. | 2021 | Details |
| A05810 | 33110211 | Exp Mol Med | The impact of endotrophin on the progression of chronic liver disease. | 2020 | Details |
| A05811 | 33110171 | Sci Rep | Impaired mitochondrial medium-chain fatty acid oxidation drives periportal macrovesicular steatosis in sirtuin-5 knockout mice. | 2020 | Details |
| A05812 | 33110165 | Sci Rep | Current NAFLD guidelines for risk stratification in diabetic patients have poor diagnostic discrimination. | 2020 | Details |
| A05813 | 33110145 | Sci Rep | NMR microsystem for label-free characterization of 3D nanoliter microtissues. | 2020 | Details |
| A05814 | 33110139 | Sci Rep | Association between noninvasive assessment of liver fibrosis and coronary artery calcification progression in patients with nonalcoholic fatty liver disease. | 2020 | Details |
| A05815 | 33109219 | Lipids Health Dis | Association between triglyceride glucose-body mass index and non-alcoholic fatty liver disease in the non-obese Chinese population with normal blood lipid levels: a secondary analysis based on a prospective cohort study. | 2020 | Details |
| A05816 | 33108854 | Diabetes Metab J | Magnetic Resonance-Based Assessments Better Capture Pathophysiologic Profiles and Progression in Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A05817 | 33108553 | J Med Ultrason (2001) | Magnetic resonance imaging for the assessment of pathological hepatic findings in nonalcoholic fatty liver disease. | 2020 | Details |
| A05818 | 33108366 | PLoS One | Hospital admission with non-alcoholic fatty liver disease is associated with increased all-cause mortality independent of cardiovascular risk factors. | 2020 | Details |
| A05819 | 33106416 | Proc Natl Acad Sci U S A | Stimulation of soluble guanylate cyclase exerts antiinflammatory actions in the liver through a VASP/NF-κB/NLRP3 inflammasome circuit. | 2020 | Details |
| A05820 | 33106141 | Curr Mol Med | Critical Role of NFκB in the Pathogenesis of Non-alcoholic Fatty Liver Disease: A Widespread Key Regulator. | 2021 | Details |
| A05821 | 33106137 | Curr Pharm Des | Therapeutic effect of Prdx1 on NAFLD mice may be related to the activation of Nrf-2/HO-1 pathway. | 2020 | Details |
| A05825 | 33105921 | Zhonghua Gan Zang Bing Za Zhi | [Elimination of hepatitis C, our progress, challenges and hopes]. | 2020 | Details |
| A05826 | 33105887 | Biology (Basel) | Lauric Acid versus Palmitic Acid: Effects on Adipose Tissue Inflammation, Insulin Resistance, and Non-Alcoholic Fatty Liver Disease in Obesity. | 2020 | Details |
| A05827 | 33105679 | Genes (Basel) | Genetic Variants Associated with Non-Alcoholic Fatty Liver Disease Do Not Associate with Measures of Sub-Clinical Atherosclerosis: Results from the IMPROVE Study. | 2020 | Details |
| A05828 | 33105604 | Int J Mol Sci | Linagliptin Ameliorates Hepatic Steatosis via Non-Canonical Mechanisms in Mice Treated with a Dual Inhibitor of Insulin Receptor and IGF-1 Receptor. | 2020 | Details |
| A05829 | 33105554 | Nutrients | Prebiotic Xylo-Oligosaccharides Ameliorate High-Fat-Diet-Induced Hepatic Steatosis in Rats. | 2020 | Details |
| A05830 | 33104787 | Phys Ther | Determinants of Physical Activity Engagement in Patients With Nonalcoholic Fatty Liver Disease: The Need for an Individualized Approach to Lifestyle Interventions. | 2021 | Details |
| A05831 | 33104014 | JMIR Res Protoc | The Effect of Multi-Parametric Magnetic Resonance Imaging in Standard of Care for Nonalcoholic Fatty Liver Disease: Protocol for a Randomized Control Trial. | 2020 | Details |
| A05832 | 33103454 | Am J Physiol Endocrinol Metab | GPR40 deficiency is associated with hepatic FAT/CD36 upregulation, steatosis, inflammation, and cell injury in C57BL/6 mice. | 2020 | Details |
| A05833 | 33103450 | Am J Physiol Endocrinol Metab | Holistic characterization of single-hepatocyte transcriptome responses to high-fat diet. | 2020 | Details |
| A05834 | 33103092 | JHEP Rep | Purinergic signalling in liver diseases: Pathological functions and therapeutic opportunities. | 2020 | Details |
| A05835 | 33102800 | Endocrinol Diabetes Metab | Perspectives on youth-onset nonalcoholic fatty liver disease. | 2020 | Details |
| A05836 | 33102799 | Endocrinol Diabetes Metab | Human and molecular genetics shed lights on fatty liver disease and diabetes conundrum. | 2020 | Details |
| A05837 | 33102798 | Endocrinol Diabetes Metab | Diagnostic and interventional circulating biomarkers in nonalcoholic steatohepatitis. | 2020 | Details |
| A05838 | 33102797 | Endocrinol Diabetes Metab | Magnetic resonance-based biomarkers in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. | 2020 | Details |
| A05839 | 33102796 | Endocrinol Diabetes Metab | The role of noninvasive biomarkers in diagnosis and risk stratification in nonalcoholic fatty liver disease. | 2020 | Details |
| A05840 | 33102794 | Endocrinol Diabetes Metab | The metabolic basis of nonalcoholic steatohepatitis. | 2020 | Details |
| A05841 | 33102791 | Endocrinol Diabetes Metab | Drug discovery and treatment paradigms in nonalcoholic steatohepatitis. | 2019 | Details |
| A05842 | 33102776 | JGH Open | Timely diagnosis and staging of non-alcoholic fatty liver disease using transient elastography and clinical parameters. | 2020 | Details |
| A05843 | 33102775 | JGH Open | Determining whether the effect of liraglutide on non-alcoholic fatty liver disease depends on reductions in the body mass index. | 2020 | Details |
| A05844 | 33102766 | JGH Open | Decrease in fasting insulin secretory function correlates with significant liver fibrosis in Japanese non-alcoholic fatty liver disease patients. | 2020 | Details |
| A05845 | 33102751 | JGH Open | Screening and follow-up of chronic liver diseases with understanding their etiology in clinics and hospitals. | 2020 | Details |
| A05846 | 33102749 | JGH Open | Epidemiology of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Japan: A focused literature review. | 2020 | Details |
| A05847 | 33102495 | Front Med (Lausanne) | miRNA Dysregulation in the Development of Non-Alcoholic Fatty Liver Disease and the Related Disorders Type 2 Diabetes Mellitus and Cardiovascular Disease. | 2020 | Details |
| A05848 | 33102399 | Can J Gastroenterol Hepatol | Characteristics of NAFLD Based on Hypopituitarism. | 2020 | Details |
| A05849 | 33102278 | J Family Med Prim Care | Prevalence of fatty liver in metabolic syndrome. | 2020 | Details |
| A05850 | 33102138 | Toxicol Rep | Welding fume inhalation exposure and high-fat diet change lipid homeostasis in rat liver. | 2020 | Details |
| A05851 | 33101626 | Frontline Gastroenterol | Non-alcoholic fatty liver disease (NAFLD) in non-obese individuals. | 2019 | Details |
| A05852 | 33101480 | Exp Ther Med | Prediction of NAFLD occurrence in prediabetes patients. | 2020 | Details |
| A05853 | 33101207 | Front Endocrinol (Lausanne) | Chinese Medicinal Herbs Targeting the Gut-Liver Axis and Adipose Tissue-Liver Axis for Non-Alcoholic Fatty Liver Disease Treatments: The Ancient Wisdom and Modern Science. | 2020 | Details |
| A05854 | 33101202 | Front Endocrinol (Lausanne) | Dynamic Changes in Circulating Endocrine FGF19 Subfamily and Fetuin-A in Response to Intralipid and Insulin Infusions in Healthy and PCOS Women. | 2020 | Details |
| A05855 | 33101026 | Front Pharmacol | Proteomics Reveal the Inhibitory Mechanism of Levodopa Against Esophageal Squamous Cell Carcinoma. | 2020 | Details |
| A05856 | 33099028 | Ann Hepatol | Association of liver steatosis and fibrosis with clinical outcomes in patients with SARS-CoV-2 infection (COVID-19). | 2020 | Details |
| A05857 | 33098868 | Arch Biochem Biophys | miR-34a regulates lipid metabolism by targeting SIRT1 in non-alcoholic fatty liver disease with iron overload. | 2020 | Details |
| A05858 | 33098092 | Hepatology | Hepatocyte Nuclear Factor 4α Prevents the Steatosis-to-NASH Progression by Regulating p53 and Bile Acid Signaling (in mice). | 2021 | Details |
| A05859 | 33098064 | Indian J Gastroenterol | Prevalence of elevated alanine aminotransferase levels in adult participants from a community-based study from northern part of India. | 2020 | Details |
| A05860 | 33098023 | Dig Dis Sci | Breaking Down Barriers to Physical Activity in Patients with Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A05861 | 33097932 | J Nutr | Soy Food Intake Is Inversely Associated with Newly Diagnosed Nonalcoholic Fatty Liver Disease in the TCLSIH Cohort Study. | 2020 | Details |
| A05862 | 33097057 | Lipids Health Dis | An inverse association of weight and the occurrence of asymptomatic gallbladder stone disease in hypercholesterolemia patients: a case-control study. | 2020 | Details |
| A05863 | 33096235 | J Nutr Biochem | Nobiletin alleviates high-fat diet-induced nonalcoholic fatty liver disease by modulating AdipoR1 and gp91phox expression in rats. | 2020 | Details |
| A05864 | 33096115 | Life Sci | The mother relationship between insulin resistance and non-alcoholic steatohepatitis: Glucosinolates hydrolysis products as a promising insulin resistance-modulator and fatty liver-preventer. | 2020 | Details |
| A05866 | 33096076 | Metabolism | Pharmacological activation of REV-ERBα improves nonalcoholic steatohepatitis by regulating intestinal permeability. | 2020 | Details |
| A05867 | 33095789 | PLoS One | Serum zinc level and hepatic fibrosis in patients with nonalcoholic fatty liver disease. | 2020 | Details |
| A05868 | 33095528 | Cell Physiol Biochem | Palmitate and Fructose Interact to Induce Human Hepatocytes to Produce Pro-Fibrotic Transcriptional Responses in Hepatic Stellate Cells Exposed to Conditioned Media. | 2020 | Details |
| A05869 | 33095225 | Food Funct | Green tea polyphenol epigallocatechin-3-gallate alleviates nonalcoholic fatty liver disease and ameliorates intestinal immunity in mice fed a high-fat diet. | 2020 | Details |
| A05870 | 33094956 | Clin Transl Gastroenterol | Feasibility of a Very Low Calorie Diet to Achieve a Sustainable 10% Weight Loss in Patients With Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A05871 | 33094480 | J Cell Physiol | SeP is elevated in NAFLD and participates in NAFLD pathogenesis through AMPK/ACC pathway. | 2020 | Details |
| A05872 | 33093663 | Nat Rev Gastroenterol Hepatol | Nonalcoholic steatohepatitis: the role of peroxisome proliferator-activated receptors. | 2020 | Details |
| A05873 | 33093014 | Diabetes | ETV5 Regulates Hepatic Fatty Acid Metabolism Through PPAR Signaling Pathway. | 2020 | Details |
| A05875 | 33092755 | JACC Clin Electrophysiol | Impact of Nonalcoholic Fatty Liver Disease on Arrhythmia Recurrence Following Atrial Fibrillation Ablation. | 2020 | Details |
| A05876 | 33092030 | Int J Mol Sci | Accumulation of 8-hydroxydeoxyguanosine, L-arginine and Glucose Metabolites by Liver Tumor Cells Are the Important Characteristic Features of Metabolic Syndrome and Non-Alcoholic Steatohepatitis-Associated Hepatocarcinogenesis. | 2020 | Details |
| A05877 | 33091447 | Life Sci | Significance of MR/OPN/HMGB1 axis in NAFLD-associated hepatic fibrogenesis. | 2020 | Details |
| A05878 | 33091218 | Liver Int | PCSK9 rs11591147 R46L loss-of-function variant protects against liver damage in individuals with NAFLD. | 2020 | Details |
| A05879 | 33091191 | Hepatol Res | Hepatocellular carcinoma and other complications of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Japan: A structured review of published works. | 2020 | Details |
| A05880 | 33090351 | Obes Surg | First Case Report of Fulminant Hepatitis After Laparoscopic Sleeve Gastrectomy Associated with Concomitant Maximal Therapeutic Dose of Acetaminophen Use, Protein Calorie Malnutrition, and Vitamins A and D, Selenium, and Glutathione Deficiencies. | 2020 | Details |
| A05881 | 33090255 | Anal Bioanal Chem | Analysis of serum lysophosphatidylethanolamine levels in patients with non-alcoholic fatty liver disease by liquid chromatography-tandem mass spectrometry. | 2020 | Details |
| A05882 | 33090099 | Turk J Gastroenterol | Morphological evaluation of the effects of exercise on high-fat-diet-induced liver damage in rats. | 2020 | Details |
| A05885 | 33089412 | J Med Ultrason (2001) | Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: new trends and role of ultrasonography. | 2020 | Details |
| A05886 | 33088441 | Int J Prev Med | Predictors of Nonalcoholic Fatty Liver Disease Among Middle-Aged Iranians. | 2020 | Details |
| A05887 | 33088301 | J Res Med Sci | Relationships between severity of steatosis with glycemic control and carotid intima-media thickness among diabetic patients with ischemic heart disease. | 2020 | Details |
| A05889 | 33086894 | Expert Opin Drug Discov | Drug development of nonalcoholic fatty liver disease: challenges in research, regulatory pathways, and study endpoints. | 2020 | Details |
| A05890 | 33086717 | J Clin Med | Relative Skeletal Muscle Mass Is an Important Factor in Non-Alcoholic Fatty Liver Disease in Non-Obese Children and Adolescents. | 2020 | Details |
| A05891 | 33086582 | Diagnostics (Basel) | The Appropriate Opportunity for Evaluating Liver Fibrosis by Using the FIB-4 Index in Patients with Nonalcoholic Fatty Liver Disease in Japan. | 2020 | Details |
| A05893 | 33085251 | Rev Med Suisse | [Bacterial infections in the context of chronic liver disease]. | 2020 | Details |
| A05894 | 33084982 | Acta Diabetol | Association of 1-deoxy-sphingolipids with steatosis but not steatohepatitis nor fibrosis in non-alcoholic fatty liver disease. | 2020 | Details |
| A05895 | 33083497 | J Immunol Res | Integrative Analyses of Genes Associated with Fulminant Type 1 Diabetes. | 2020 | Details |
| A05896 | 33083258 | J Clin Transl Hepatol | Hypothyroidism and Nonalcoholic Fatty Liver Disease: Pathophysiological Associations and Therapeutic Implications. | 2020 | Details |
| A05897 | 33083254 | J Clin Transl Hepatol | Antihepatic Fibrosis Drugs in Clinical Trials. | 2020 | Details |
| A05898 | 33083247 | J Clin Transl Hepatol | Efficacy and Safety of All-oral Emitasvir and Sofosbuvir in Patients with Genotype 1b HCV Infections without Cirrhosis. | 2020 | Details |
| A05899 | 33081717 | BMC Gastroenterol | A hypocaloric high-protein diet supplemented with β-cryptoxanthin improves non-alcoholic fatty liver disease: a randomized controlled trial. | 2020 | Details |
| A05900 | 33081272 | Life (Basel) | Deregulated Serotonin Pathway in Women with Morbid Obesity and NAFLD. | 2020 | Details |
| A05901 | 33081177 | Nutrients | Pediatric Non-Alcoholic Fatty Liver Disease: Nutritional Origins and Potential Molecular Mechanisms. | 2020 | Details |
| A05902 | 33081022 | Int J Mol Sci | Impact of Mitophagy and Mitochondrial Unfolded Protein Response as New Adaptive Mechanisms Underlying Old Pathologies: Sarcopenia and Non-Alcoholic Fatty Liver Disease. | 2020 | Details |
| A05903 | 33080906 | Medicina (Kaunas) | Silymarin in Combination with Vitamin C, Vitamin E, Coenzyme Q10 and Selenomethionine to Improve Liver Enzymes and Blood Lipid Profile in NAFLD Patients. | 2020 | Details |
| A05904 | 33080603 | Digestion | Lipoprotein and Metabolic Profiles Indicate Similar Cardiovascular Risk of Liver Steatosis and NASH. | 2020 | Details |
| A05905 | 33079971 | PLoS One | Selecting the best machine learning algorithm to support the diagnosis of Non-Alcoholic Fatty Liver Disease: A meta learner study. | 2020 | Details |
| A05906 | 33079776 | Eur J Gastroenterol Hepatol | A prospective cohort study of the use of the fatty liver index and Fibroscan to determine the prevalence of fatty liver disease in an Irish population. | 2022 | Details |
| A05907 | 33079450 | Mol Nutr Food Res | The Beneficial Effects of Apical Sodium-Dependent Bile Acid Transporter Inactivation Depend on Dietary Fat Composition. | 2020 | Details |